维普中文期刊产品整合服务
8篇 您的检索式:作者名="Brell JM"
    题名 作者 年代 出处 被引量
1Phase ]I study of docetaxel and gefitinib as second-line therapy in gemcitabine pretreated patients with advanced pancreatic cancer显示文摘Brell JM Matin K Evans T eta/ 2009Oncology2009,76,4:1
2Discovering cytokines as tar- gets for chemotherapy induced painful peripheral neuropathy 显示文摘Wang XM Lehky TJ Brell JM 2012Cy- tokine2012,59,1:1
3Phase II study of docetaxel and gefitinib as second-line therapy in gem- citabine pretreated patients with advanced pancreatic cancer显示文摘Brell JM Matin K Evans T 2009Oncology2009,76,4:1
4A muhi-center phase Ⅱ study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroe- sophageal junction carcinoma 显示文摘Brell JM Krishnamurthi SS Javle M 2009Cancer Chemother Pharmaco12009,63,5:1
5Phase II study of docetaxel and gefitinib as second-line therapy in gemcitabine pretreated patients with advanced pancreatic cancer显示文摘Brell JM Matin K Evans T 2009Oncology2009,76,4:1
6Phase I1 study of doeetaxel and gefitinib as second-line therapy in gemcitabine pretreated patientswith advanced pancreatic cancer 显示文摘Brell JM Matin K Evans T 2009Oncology2009,76,4:1
7Discovering cy- tokines as targets for chemotherapy-induced painful peripheral neuropathy显示文摘Wang XM Lehky TJ Brell JM 2012Cytokine2012,59,1:1
8Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy显示文摘Wang XM Lehky TJ Brell JM 2012Cytokine2012,59,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费